Tolerability and diagnostic usefulness of iohexol in urography. An open multicentre clinical trial.
The first experience with iohexol in urography in humans is reported. Injection of iohexol in a dose of 200 mg I/kg body weight into 34 patients with normal renal function was followed by only few and slight subjective adverse effects. A large number of laboratory tests revealed no toxic effects. High radiographic contrast was obtained.
D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D002986:Clinical Trials as Topic; D003287:Contrast Media; D004573:Electrolytes / Q000097:blood / Q000652:urine; D004798:Enzymes / Q000097:blood; D005260:Female; D006400:Hematocrit; D006801:Humans; D007463:Iodobenzoates; D007472:Iohexol; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000097:blood / Q000000981:diagnostic imaging; D013997:Time Factors; D014283:Triiodobenzoic Acids; D014549:Urinary Incontinence / Q000097:blood / Q000000981:diagnostic imaging; D014552:Urinary Tract Infections / Q000097:blood / Q000000981:diagnostic imaging; D014567:Urography / Q000379:methods*
D003287:Contrast Media; D004573:Electrolytes; D004798:Enzymes; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007472:Iohexol